MedTrace Logo

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

NCT02877706 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-12-31

No results posted yet for this study

Summary

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

Conditions

Interventions

OTHER

no specific intervention

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Moulis Guillaume, MD PhD · University Hopsital Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2026-12-31
Completion
2029-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877706 on ClinicalTrials.gov